Medication against breast cancer and related diseases

Details for Australian Patent Application No. 2007251823 (hide)

Owner MaBel GmbH

Inventors Teichmann, Alexander Tobias

Agent Fisher Adams Kelly

Pub. Number AU-B-2007251823

PCT Pub. Number WO2007/131737

Priority 06009894.4 12.05.06 EP; 60/747,124 12.05.06 US

Filing date 11 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 6 September 2012

International Classifications

A61K 31/568 - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 5/26 Drugs for disorders of the endocrine system

A61P 35/00 Antineoplastic agents

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/131737 Priority application(s): WO2007/131737

24 June 2010 Assignment before Grant

  Teichmann, Alexander The application has been assigned to MaBel GmbH

6 September 2012 Application Accepted

  Published as AU-B-2007251823

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251849-Process for the production of yeast

2007251822-Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers